EHS
EHS

Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant

Money currency vector illustration. Various money bills dollar cash paper bank notes and gold coins. Collection of cash heap pile and currency stack vector set.

The company plans to use the funding to advance LYR-210 into a Phase II clinical trial and also explore its development platform in other ENT diseases.

EHS
Back to top button